Clinical Scorecard: Transforming Preclinical Drug Discovery: The Impact of AI on Virtual Molecules and Clinical Trials
At a Glance
Category
Detail
Condition
Key Mechanisms
Artificial intelligence (AI) technologies, including machine learning (ML) and deep learning (DL), enhance drug candidate identification, design, and optimization.
Target Population
Care Setting
Key Highlights
AI enables efficient identification and optimization of drug candidates.
Machine learning and deep learning improve prediction of drug-target interactions.
Generative chemistry creates novel compounds with pharmaceutical potential.
AI-driven platforms have advanced drug candidates into clinical trials.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
High failure rates in clinical trials primarily due to lack of clinical efficacy and toxicity.
Patient & Prescribing Data
Not specified; relevant to drug development processes.
AI models assess absorption, distribution, metabolism, excretion, and toxicity features.
Clinical Best Practices
Integrate virtual screening and molecular docking in drug discovery pipelines.
Utilize machine learning algorithms for predicting drug-target interactions.
